Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

68
Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
68
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

50.1K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
50.1K
Teratogenicity01:07

Teratogenicity

4.4K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.4K
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

14.3K
The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
14.3K
Retroviruses02:33

Retroviruses

15.3K
Retroviruses and retrotransposons both insert copies of their genetic elements into the genome of the host cell. Thus, the viral genes are passed on when the host genome is replicated or translated. A typical retroviral DNA sequence contains 3-4 genes that encode the different proteins required for its structural assembly and function as a molecular parasite. This DNA is transcribed into a single mRNA, which is very similar in structure to conventional mRNAs, i.e., it is capped at the 5’...
15.3K
Viral Mutations00:36

Viral Mutations

40.3K
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
40.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

AcTor, a novel mTOR stimulator, potentiates ixazomib for the treatment of acute myeloid leukemia.

Molecular cancer·2026
Same author

On the state of protein function prediction: a report on the fourth CAFA challenge.

bioRxiv : the preprint server for biology·2026
Same author

AcTor, a novel mTOR stimulator, potentiates ixazomib for the treatment of acute myeloid leukemia.

Research square·2026
Same author

Discovery of synthetic G-quadruplex DNA as SARS-CoV-2 helicase inhibitor with antiviral, anti-inflammatory and antioxidative properties.

Cell death discovery·2026
Same author

Cell culture pioneer Jaroslav Cinatl-the pursuit and defence of truth.

FEBS letters·2025
Same author

Evaluation of Surveillance for Suspected Human Exposure to Rabies, Washington State, 2018-2023.

Public health reports (Washington, D.C. : 1974)·2025
Same journal

Enteric populations of <i>Escherichia coli</i> are likely to be resistant to phages due to O antigen expression.

mSphere·2026
Same journal

Comparative analysis of gut viromes in four penguin species reveals diverse novel viruses and host-associated differences.

mSphere·2026
Same journal

Systems analysis reveals alternate metabolic states adopted by <i>Mycobacterium tuberculosis</i> across species.

mSphere·2026
Same journal

HIV-1 and <i>Chlamydia trachomatis</i> limit their respective growth but promote their survival in co-infected human macrophages.

mSphere·2026
Same journal

Salinity-driven microbial adaptation of hydrocarbon-degrading communities in coastal sediments.

mSphere·2026
Same journal

Tools for genetic manipulation of the endemic fungal pathogen <i>Emergomyces africanus</i> and application of a fluorescent reporter strain in infection models.

mSphere·2026
See all related articles

Related Experiment Video

Updated: Mar 9, 2026

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks
10:28

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks

Published on: June 26, 2020

10.4K

Risks Posed by Reston, the Forgotten Ebolavirus.

Diego Cantoni1, Arran Hamlet2, Martin Michaelis1

  • 1School of Biosciences, University of Kent, Canterbury, United Kingdom.

Msphere
|January 10, 2017
PubMed
Summary
This summary is machine-generated.

Reston virus (RESTV) is nonpathogenic to humans, unlike other Ebolaviruses. Differences in viral proteins, particularly VP24 and glycoprotein, influence pathogenicity, but the exact factors remain unclear, necessitating further research for disease prevention.

Keywords:
EbolavirusRestonpathogenicity

More Related Videos

Transsynaptic Tracing from Peripheral Targets with Pseudorabies Virus Followed by Cholera Toxin and Biotinylated Dextran Amines Double Labeling
13:12

Transsynaptic Tracing from Peripheral Targets with Pseudorabies Virus Followed by Cholera Toxin and Biotinylated Dextran Amines Double Labeling

Published on: September 14, 2015

13.8K
Stereotaxic Microinjection of Viral Vectors Expressing Cre Recombinase to Study the Role of Target Genes in Cocaine Conditioned Place Preference
08:22

Stereotaxic Microinjection of Viral Vectors Expressing Cre Recombinase to Study the Role of Target Genes in Cocaine Conditioned Place Preference

Published on: July 30, 2013

19.2K

Related Experiment Videos

Last Updated: Mar 9, 2026

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks
10:28

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks

Published on: June 26, 2020

10.4K
Transsynaptic Tracing from Peripheral Targets with Pseudorabies Virus Followed by Cholera Toxin and Biotinylated Dextran Amines Double Labeling
13:12

Transsynaptic Tracing from Peripheral Targets with Pseudorabies Virus Followed by Cholera Toxin and Biotinylated Dextran Amines Double Labeling

Published on: September 14, 2015

13.8K
Stereotaxic Microinjection of Viral Vectors Expressing Cre Recombinase to Study the Role of Target Genes in Cocaine Conditioned Place Preference
08:22

Stereotaxic Microinjection of Viral Vectors Expressing Cre Recombinase to Study the Role of Target Genes in Cocaine Conditioned Place Preference

Published on: July 30, 2013

19.2K

Area of Science:

  • Virology
  • Pathogen Evolution

Background:

  • Four of the five Ebolavirus species cause severe human disease, while Reston virus (RESTV) does not.
  • The molecular basis for RESTV's nonpathogenicity in humans compared to other Ebolaviruses is not well understood.
  • RESTV is phylogenetically close to the highly pathogenic Sudan virus, adding to the mystery of its differing pathogenicity.

Approach:

  • This review synthesizes current knowledge on factors influencing Ebolavirus pathogenicity in humans.
  • Analysis includes comparative genomics, protein sequence differences, and functional implications of viral immune evasion mechanisms.
  • Recent *in silico* studies examining sequence variations between RESTV and pathogenic Ebolaviruses are considered.

Key Points:

  • Amino acid sequence variations exist across all nine Ebolavirus proteins between RESTV and pathogenic strains.
  • Specific viral proteins, including the glycoprotein, VP24, and VP35, show differences linked to pathogenicity and immune evasion.
  • No single amino acid residue has been identified as solely responsible for conferring pathogenicity.

Conclusions:

  • The precise determinants of Ebolavirus pathogenicity in humans are still not fully elucidated.
  • Understanding these factors is critical for preventing Ebolavirus disease and for early detection of potentially emergent, human-pathogenic RESTV strains.